These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19437490)

  • 1. L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats.
    Davies NA; Wright G; Ytrebø LM; Stadlbauer V; Fuskevåg OM; Zwingmann C; Davies DC; Habtesion A; Hodges SJ; Jalan R
    Hepatology; 2009 Jul; 50(1):155-64. PubMed ID: 19437490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ammonia reduction with ornithine phenylacetate restores brain eNOS activity via the DDAH-ADMA pathway in bile duct-ligated cirrhotic rats.
    Balasubramaniyan V; Wright G; Sharma V; Davies NA; Sharifi Y; Habtesion A; Mookerjee RP; Jalan R
    Am J Physiol Gastrointest Liver Physiol; 2012 Jan; 302(1):G145-52. PubMed ID: 21903766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure.
    Ytrebø LM; Kristiansen RG; Maehre H; Fuskevåg OM; Kalstad T; Revhaug A; Cobos MJ; Jalan R; Rose CF
    Hepatology; 2009 Jul; 50(1):165-74. PubMed ID: 19554542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in hyperammonaemia by ornithine phenylacetate prevents lipopolysaccharide-induced brain edema and coma in cirrhotic rats.
    Wright G; Vairappan B; Stadlbauer V; Mookerjee RP; Davies NA; Jalan R
    Liver Int; 2012 Mar; 32(3):410-9. PubMed ID: 22151131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ornithine phenylacetate targets alterations in the expression and activity of glutamine synthase and glutaminase to reduce ammonia levels in bile duct ligated rats.
    Jover-Cobos M; Noiret L; Lee K; Sharma V; Habtesion A; Romero-Gomez M; Davies N; Jalan R
    J Hepatol; 2014 Mar; 60(3):545-53. PubMed ID: 24512823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interorgan metabolism of ornithine phenylacetate (OP)--a novel strategy for treatment of hyperammonemia.
    Dadsetan S; Sørensen M; Bak LK; Vilstrup H; Ott P; Schousboe A; Jalan R; Keiding S; Waagepetersen HS
    Biochem Pharmacol; 2013 Jan; 85(1):115-23. PubMed ID: 23103564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ornithine phenylacetate prevents disturbances of motor-evoked potentials induced by intestinal blood in rats with portacaval anastomosis.
    Oria M; Romero-Giménez J; Arranz JA; Riudor E; Raguer N; Córdoba J
    J Hepatol; 2012 Jan; 56(1):109-14. PubMed ID: 21835138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy.
    Jalan R; Wright G; Davies NA; Hodges SJ
    Med Hypotheses; 2007; 69(5):1064-9. PubMed ID: 17467190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ornithine phenylacetate revisited.
    Jover-Cobos M; Noiret L; Sharifi Y; Jalan R
    Metab Brain Dis; 2013 Jun; 28(2):327-31. PubMed ID: 23456516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-Ornithine phenylacetate reduces ammonia in pigs with acute liver failure through phenylacetylglycine formation: a novel ammonia-lowering pathway.
    Kristiansen RG; Rose CF; Fuskevåg OM; Mæhre H; Revhaug A; Jalan R; Ytrebø LM
    Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G1024-31. PubMed ID: 25258408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension.
    Jalan R; De Chiara F; Balasubramaniyan V; Andreola F; Khetan V; Malago M; Pinzani M; Mookerjee RP; Rombouts K
    J Hepatol; 2016 Apr; 64(4):823-33. PubMed ID: 26654994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of ornithine phenylacetate in cirrhotic decompensated patients: an open-label, dose-escalating, single-cohort study.
    Ventura-Cots M; Arranz JA; Simón-Talero M; Torrens M; Blanco A; Riudor E; Fuentes I; Suñé P; Soriano G; Córdoba J
    J Clin Gastroenterol; 2013; 47(10):881-7. PubMed ID: 23751856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics/pharmacodynamics of L-ornithine phenylacetate in overt hepatic encephalopathy and the effect of plasma ammonia concentration reduction on clinical outcomes.
    Safadi R; Rahimi RS; Thabut D; Bajaj JS; Ram Bhamidimarri K; Pyrsopoulos N; Potthoff A; Bukofzer S; Wang L; Jamil K; Devarakonda KR
    Clin Transl Sci; 2022 Jun; 15(6):1449-1459. PubMed ID: 35238476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current state of knowledge of hepatic encephalopathy (part I): newer treatment strategies for hyperammonemia in liver failure.
    Kristiansen RG
    Metab Brain Dis; 2016 Dec; 31(6):1357-1358. PubMed ID: 27651377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotoxemia produces coma and brain swelling in bile duct ligated rats.
    Wright G; Davies NA; Shawcross DL; Hodges SJ; Zwingmann C; Brooks HF; Mani AR; Harry D; Stadlbauer V; Zou Z; Williams R; Davies C; Moore KP; Jalan R
    Hepatology; 2007 Jun; 45(6):1517-26. PubMed ID: 17523148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile-duct ligation renders the brain susceptible to hypotension-induced neuronal degeneration: Implications of ammonia.
    Clément MA; Bosoi CR; Oliveira MM; Tremblay M; Bémeur C; Rose CF
    J Neurochem; 2021 May; 157(3):561-573. PubMed ID: 33382098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of ornithine phenylacetate (OCR-002) in lowering plasma ammonia after upper gastrointestinal bleeding in cirrhotic patients.
    Ventura-Cots M; Concepción M; Arranz JA; Simón-Talero M; Torrens M; Blanco-Grau A; Fuentes I; Suñé P; Alvarado-Tapias E; Gely C; Roman E; Mínguez B; Soriano G; Genescà J; Córdoba J
    Therap Adv Gastroenterol; 2016 Nov; 9(6):823-835. PubMed ID: 27803737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of phenylbutyrate metabolites by UPLC-MS/MS demonstrates inverse correlation of phenylacetate:phenylacetylglutamine ratio with plasma glutamine levels.
    Jiang Y; Almannai M; Sutton VR; Sun Q; Elsea SH
    Mol Genet Metab; 2017 Nov; 122(3):39-45. PubMed ID: 28888854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal brain oxygen homeostasis in an animal model of liver disease.
    Hadjihambi A; Cudalbu C; Pierzchala K; Simicic D; Donnelly C; Konstantinou C; Davies N; Habtesion A; Gourine AV; Jalan R; Hosford PS
    JHEP Rep; 2022 Aug; 4(8):100509. PubMed ID: 35865351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ammonia mediates cortical hemichannel dysfunction in rodent models of chronic liver disease.
    Hadjihambi A; De Chiara F; Hosford PS; Habtetion A; Karagiannis A; Davies N; Gourine AV; Jalan R
    Hepatology; 2017 Apr; 65(4):1306-1318. PubMed ID: 28066916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.